Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdoid Tumor × talazoparib × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 5 Advanced Solid Tumors 4 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Pancreatic Neoplasms 2 Neoplasms 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Fanconi Anemia, Complementation Group D1 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Adenocarcinoma 1 Advanced Solid Tumor 1 Advanced Ovarian Cancer 1 ATM Gene Mutation 1

Interventions

X-Rays 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 tazemetostat 3 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Vincristine 2 Radiotherapy 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Biopsy 2 ulixertinib 1 tipifarnib 1 selpercatinib 1 ribociclib 1 palbociclib 1 olaparib 1 merphos 1 larotrectinib 1 etoposide phosphate 1 erdafitinib 1 dinutuximab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 abemaciclib 1 Vemurafenib 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡